# Isoechoic Renal Tumors: A Case Report and Literature Review

## TL;DR

This paper discusses the challenges of diagnosing isoechoic kidney tumors and highlights the need for advanced imaging and new technologies to improve detection and treatment decisions.

## Contribution

The paper emphasizes the importance of multimodal diagnostic approaches and emerging technologies for managing isoechoic renal tumors.

## Key findings

- Isoechoic renal tumors are difficult to detect with conventional ultrasound but can be better identified with contrast-enhanced ultrasound.
- Multiparametric MRI and dual-energy CT offer high accuracy in differentiating benign and malignant isoechoic lesions.
- Emerging technologies like AI-enhanced imaging and liquid biopsy are being explored for better diagnosis and management.

## Abstract

Background and Clinical Significance: Isoechoic renal tumors, defined as masses demonstrating echogenicity similar to normal renal parenchyma, represent a significant diagnostic challenge in contemporary ultrasonographic practice. These lesions, occurring in 5–12% of all renal masses, frequently escape detection on conventional ultrasound, leading to delayed diagnosis and potentially adverse oncological outcomes. Isoechoic renal tumors encompass both benign and malignant entities, with clear cell renal cell carcinoma representing 65–70% of malignant cases. Conventional ultrasound shows limited sensitivity (48–67%) for detecting isoechoic masses, while contrast-enhanced ultrasound achieves detection rates of 94–98%. Multiparametric MRI and dual-energy CT provide superior characterization, with accuracy rates of 85–92% for differentiating benign from malignant lesions. Case Presentation: We describe the case of an 80-year-old male in whom a 2.4 cm isoechoic renal mass was incidentally detected during abdominal ultrasound performed for chronic kidney disease monitoring. Contrast-enhanced CT confirmed a solid, hypervascular lesion with wash-out characteristics. Given the patient’s age, comorbidities, and tumor characteristics, multidisciplinary evaluation led to an active surveillance strategy. At 6-month follow-up, the lesion remained stable. Conclusions: Isoechoic renal tumors require multimodal diagnostic approaches and individualized management strategies. Emerging technologies, including artificial intelligence-enhanced ultrasound systems and radiomic-based decision support tools, are undergoing clinical validation and may improve detection and characterization. Investigational approaches such as liquid biopsy and novel PET tracers targeting carbonic anhydrase IX are in early development. Translation of these technologies into clinical practice will require prospective validation, standardization of protocols, and demonstration of cost-effectiveness.